Elevated DNMT1 expression in DKD mononuclear cells induces mTOR-related methylation changes and inflammation, reversible through DNMT1 inhibition with 5-aza-2′-deoxycytidine (5-aza), offering a new therapeutic perspective [175]. The gene discussed is DNMT1; the disease is diabetic kidney disease.